cAMP has been implicated in the control of the expression of developmental genes in Dictyostelium discoi- We have recently characterized two cAMP binding proteins in developing D. discoideum cells, termed CABP1 and CABP2 (19). CABP1 is an unusual cAMP binding protein in that it consists oftwo subunits of different molecular weights. CABP2 has properties identical to the regulatory subunit of the cAMP-dependent protein kinase, which has been characterized extensively by other workers (20-30). The subcellular localization of the regulatory subunit of cAMP-dependent protein kinase has been examined before (22, 30) . In the present communication, we have examined the subcellular localization of CABP1 during development. CABP1 is found in the intracellular fraction as well as on the surface of developing cells. During development, CABP1 is translocated to the nucleus. This pattern of cellular localization is compatible with the idea that CABP1 plays a pivotal role in mediating the effect of cAMP on developmental gene expression.
anti-CABP1 to intact cells followed by reaction with 1251 labeled secondary antibody revealed that the cell-surface CABP1 activity peaks during aggregation and culmination. In addition, several proteins related to CABP1 are found mainly in the nuclear fraction of developing cells. The possible role of these proteins in the regulation of developmental gene activity is discussed.
One of the many functions of cAMP in eukaryotic cells is its involvement in the regulation of gene expression (1) (2) (3) (4) (5) (6) . Although the mode of action of cAMP on gene expression is well-characterized in prokaryotic systems (7) , little is known of its mechanisn(s) in eukaryotic cells. The observation that the 5' flanking regions of cAMP-regulated genes in eukaryotes share extensive homology with their bacterial counterparts implies that a protein similar to the cAMP receptor protein (CRP) of Escherichia coli may mediate the effects of cAMP (5) . No such protein has yet been identified in eukaryotic cells. Until recently, the only known cAMP binding proteins in eukaryotes were the two regulatory subunits (RI and RI,) of cAMP-dependent protein kinases. Homology between the RI, subunit and the CRP ofE. coli has been established, but it is confined to the cAMP binding domain and not the DNA binding domain of CRP (8) .
However, a recent claim that the phosphoform of the RI, subunits possesses topoisomerase activity is consistent with the idea that this protein may interact directly with DNA (9) .
The cellular slime mold Dictyostelium discoideum offers an attractive system to analyze the control of gene activity by cAMP because of its relative simplicity and because of the dramatic effect cAMP has on its developmental gene expression. Amoebae of D. discoideum commence development when deprived of nutrients. Approximately 8 hr after starvation, the cells aggregate to form multicellular structures, which eventually develop into fruiting bodies consisting of spores and stalk cells. Besides acting as a chemotactic agent in the process of aggregation (10) , extracellular cAMP serves as an effector for the expression of most, if not all, developmentally regulated genes (11) (12) (13) (14) (15) (16) (17) . Thus a cell-surface cAMP receptor is implicated. The detection of cAMP by immunofluorescence in the nuclei as well as the cytoplasm of developing cells suggests that the nucleus contains cAMP receptors (18) . These results suggest that the mediator of the cAMP effect on gene activity is present in different compartments of developing cells and/or that several cAMP receptors are involved. It therefore becomes of interest to examine the subcellular location of cAMP-binding proteins during development.
We have recently characterized two cAMP binding proteins in developing D. discoideum cells, termed CABP1 and CABP2 (19) . CABP1 is an unusual cAMP binding protein in that it consists oftwo subunits of different molecular weights. CABP2 has properties identical to the regulatory subunit of the cAMP-dependent protein kinase, which has been characterized extensively by other workers (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . The subcellular localization of the regulatory subunit of cAMP-dependent protein kinase has been examined before (22, 30) . In the present communication, we have examined the subcellular localization of CABP1 during development. CABP1 is found in the intracellular fraction as well as on the surface of developing cells. During development, CABP1 is translocated to the nucleus. This pattern of cellular localization is compatible with the idea that CABP1 plays a pivotal role in mediating the effect of cAMP on developmental gene expression.
MATERIALS AND METHODS
Conditions of Growth and Development. The D. discoideum strain NC4 used in this study was originally isolated by K. Raper (Univ. of Wisconsin, Madison). The cells were grown in association with Enterobacter aerogenes on SM agar (31) in the dark at 220C for [40] [41] [42] [43] [44] 
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The remaining suspension was Vortex mixed for 1 min. After this manipulation cell lysis was routinely found to be >95%. Unbroken cells were removed by centrifugation at 400 x g for 5 min. A further centrifugation at 2000 x g pelleted the nuclei leaving the postnuclear fraction in the supernatant. The nuclei were then washed twice with NIB by centrifugation at 2000 x g to yield the nuclear fraction.
The postnuclear supernatant fluid was clarified by centrifugation at 20 ,000 x g for 20 min. This step removed residual nuclei and other detergent-insoluble materials. The resulting postnuclear supernatant fraction was also referred to as cytoplasmic fraction. All samples isolated were treated immediately with NaDodSO4 sample buffer (33) for 2 min at 90'C. The samples were then centrifuged for 2 min at 12,000 x g to remove insoluble materials.
Immunoblotting. Protein samples were resolved in 12% NaDodSO4/polyacrylamide gels. Unless otherwise specified, 10 Ag of protein was used in each sample. After electrophoresis, the polypeptides on the gels were transferred onto nitrocellulose filters (Schleicher & Schuell BA85) as described (34) . The filters were probed with a mixture of three monoclonal antibodies-B9, Eli, and F8-as described (19) .
Quantification of CABP1 in the Nucleus. After exposing the immunoblot for different lengths of time, the bands corresponding to the two subunits of CABP1 were quantified by densitometry (EC910 densitometer). Since 10 Ag of protein per fraction was examined by immunoblotting, the protein concentrations in various fractions were taken into consideration when determining the levels ofnuclear CABP1. Using the above method of nuclear isolation, the percentages of cellular protein found in the nuclear fractions vary slightly during development: 3 
RESULTS
Localization of CABP1 by Immunoblotting. The anti-CABP1 monoclonal antibodies used in this study were characterized in a previous report (19) . These antibodies react with both subunits of CABP1, which in strain NC4 have molecular weights of 43,000 and 38,000 (36) . The monoclonal antibodies also crossreact with four other polypeptides with molecular weights of 70,000, 50,000, 34,000, and 31,000 (19) .
For immunoblotting, extracts of Dictyostelium cells from various stages of development were partitioned into nuclear and postnuclear supernatant fractions as described in Materials and Methods. Ten micrograms of protein from each fraction was resolved on 12% NaDodSO4/polyacrylamide gels, transferred onto nitrocellulose filters, and probed with specific antibodies. Fig. 1 shows an autoradiogram of a typical experiment when anti-CABP1 monoclonal antibodies were used as probes. Most of the CABP1 antigen was localized in the cytoplasmic fraction of vegetative cells with a small but detectable amount in the nucleus. In the later stages of development, a substantial amount of CABP1 was detected in the nuclear fraction. 2 . Levels of CABP1 in the nuclear fractions of developing cells. The levels of CABP1 in the subcellular fractions were determined as described in Fig. 1 . The immunoblots were exposed to x-ray films for various lengths of time and the intensities of the radioactivity bands on the autoradiograms were quantified by densitometry as described in Materials and Methods. The amount of CABP1 in the nuclear fraction was expressed as a percentage of the total CABP1 activity. Results from four independent experiments are shown. The curve was drawn through the averages of these determinations. development (36) , the amount of CABP1 in the nucleus of 16-hr cells is therefore >30 times higher than the amount of CABP1 in the nucleus of vegetative cells.
As mentioned earlier, the anti-CABP1 monoclonal antibodies crossreact with several other polypeptides. These polypeptides are not modification products of CABP1 but are derived from primary translation products (19, 36) . Although the function of these polypeptides is not known, they appear to be closely related to CABP1. They copurify with CABP1 (19) , and the genes encoding these polypeptides share extensive homology with the CABP1 gene (unpublished data). Three of the crossreacting polypeptides of Mr 70,000, Mr 34,000, and Mr 31,000 were detected mainly in the nuclear fractions. Two additional polypeptides of Mr 41,000 and 39,000 were found in the nuclear fraction. Quantification by densitometry revealed that >40% of these polypeptides was found in the nuclear fractions of developing cells. Since some nuclei were lost or lysed during isolation, the levels of these polypeptides in the nucleus might have been underestimated. Furthermore, while CABP1 and the Mr 34,000 and Mr 31,000 polypeptides increased in concentration steadily during development, the other crossreacting polypeptides appeared to peak at the time of aggregation (Fig. 1) .
Localization of cAMP Receptors by Immunofluorescence. To complement the results described above, we used an immunocytochemical approach to localize the CABPs in Dictyostelium cells. In some experiments, the location of the nuclei was ascertained by double staining with the antibodies and the nuclear dye bisbenzimide H33258 (data not shown). To avoid the potential problem of contaminating fluorescence, the experiment described here was performed with antibodies only. Staining with anti-CABP1 shows that in vegetative and early developing cells the CABP1 antigen was concentrated in the cytoplasm near the cell periphery (Fig. 3  a-c) . In the later stages of development, especially following tip formation (12 hr of development), the staining of CABP1 was most pronounced in the nucleus and in a thick band in the cell periphery (Fig. 3 d-J) . Although the nuclear proteins described in Fig. 1 might have contributed to the nuclear staining, these results suggest that a portion of CABP1 is translocated to the nucleus during development while a substantial amount stays at the cell periphery.
Previously, we reported that mouse antisera raised against CABP2, the regulatory subunits of the cAMP-dependent protein kinase, crossreact with CABP1. We have recently obtained rabbit sera that are highly specific for CABP2 (unpublished data). When the rabbit anti-CABP2 antigen was used to stain cells that had been developed for 8 hr, the CABP2 antigen was found to be diffusely distributed throughout the cells (Fig. 3h) . A similar pattern of staining was observed for cells from other stages of development (data not shown).
Detection of CABP1 on the Cell Surface. The finding of CABP1 at the cell periphery suggests that some of the CABP1 activity may be on the cell surface. The experiment shown in Fig. 3 was done with methanol-fixed cells, which allowed effective detection of intracellular antigens but made analysis of cell-surface antigens difficult. We found that D. discoideum cells that had been fixed with 2% paraformaldehyde were impermeable to antibodies. This provided us with a convenient method of detecting cell-surface antigens. After fixation with 2% paraformaldehyde, we detected only background staining with anti-CABP2 (Fig. 4d) . Fig. 4e shows that an identical result was obtained with a monoclonal antibody that reacts with a prespore antigen (37) . However, we observed staining on the cell surface when anti-CABP1 underwent reaction with paraformaldehyde-fixed cells (Fig. 4) . This implies that CABP1 also resides on the cell surface. Moreover, the staining of CABP1 on the cell surface was most intense at the time of aggregation, at a reduced level for late developing cells, and was not detected in vegetative cells.
The reactivity of anti-CABP1 with the cell surface prompted us to examine the levels of CABP1 on the surface of developing cells by using a semi-quantitative method described in Materials and Methods. Fig. 5 shows the binding profiles of anti-CABP1 and anti-CABP2 to developing cells. No binding of anti-CABP2 was detected under these conditions. Anti-CABP1 was found to bind to the surface of cells from all stages of development with two distinct peaks: one at early aggregation and the other during terminal differen- tiation. Together with the immunofluorescence data, these results suggest that CABP1 is also located on the surface of developing cells and that aggregating and culminating cells possess higher cell-surface CABP1 activity than cells from other stages of development. In addition, the level of CABP1 on the surface of postaggregative cells was consistently 2-3 times higher than that of preaggregative cells. Interestingly, such a profile is quite different from that of the total CABP1 activity (19) but is similar to the developmental profile of cAMP accumulation (38) or that of the major cell-surface cAMP receptor (39) .
DISCUSSION
Results from several laboratories have demonstrated that cAMP affects the expression of developmental genes in D. discoideum, at least in part, by changing their rates of transcription and by stabilizing developmental mRNAs (1, 12) . The expression of most developmental genes is regulated by extracellular cAMP (11, 15, 17) , suggesting that cellsurface cAMP receptors are involved. In addition, immunofluorescence studies showed cAMP is distributed throughout the cells, including the nuclei of developing cells (18) . For the cAMP to be detected by this technique would imply that cAMP receptors also reside in the nuclei. Taken together, these results imply that the cAMP receptor that regulates developmental gene expression is translocated from the cell surface to the nucleus during development. We report here that CABP1 is detected on the cell surface and in the intracellular fraction of developing cells. Moreover, CABP1 is translocated to the nucleus during development (Figs. 1-3) . A simple interpretation of these results is that CABP1 is involved in the regulation of developmental gene activity in this organism. The finding that a change in developmental program is correlated with an altered CABP1 (36) is another line of evidence that supports the idea that CABP1 is a mediator ofthe effect of cAMP on developmental gene expression.
While the developmental profiles of the cell-surface CABP1 and the chemotactic receptor are similar (ref. 39 ; Fig.  5 ), the properties of these two proteins are very different (19, 40) . Thus, it is unlikely that the cell-surface CABP1 also serves as the chemotactic receptor. In other words, CABP1 and the chemotactic receptor can coexist on the cell surface. This may explain why kinetic studies show that the cellsurface cAMP binding activity is heterogeneous (41) .
The difference in developmental profile for the cell-surface CABP1 and the total CABP1 activity is intriguing (refs. 19 and 36; Figs. 1 and 5 ). The effect of cAMP on gene expression is not confined to discrete stages of development. If the sole function of the cell-surface CABP1 is to regulate gene activity, there should be no requirement for it to peak at aggregation and culmination. One possibility is that the peak activities of cell-surface CABP1 reflect the levels of gene activity during development. Since the major shifts in gene activity during development occur shortly after aggregation and during culmination (42, 43) , the cells may increase cell-surface CABP1 activity to coincide with these events. In addition, the levels of cAMP also peak at aggregation and culmination (38) . This would imply that the levels of cAMP and cell-surface CABP1 are coordinated to regulate gene activity. However, the present data do not allow us to rule out other possibilities, including some trivial ones.
The regulatory subunit of cAMP-dependent protein kinase is the best characterized cAMP binding protein in Dictyostelium (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . This protein has been suggested to play a role in gene regulation (30) . Whereas Woffendin et al. (30) showed a translocation of this protein to the nucleus during development, Part et al. (22) reported that this protein is found only in the cytoplasmic fraction. We have also examined the localization of this protein in developing cells by immunoblotting and immunocytochemistry. In these experiments, the regulatory subunit of cAMP-dependent protein kinase was detected only in the cytoplasmic fractions of developing cells except during culmination, where -4% of this protein was detected in the nuclear fraction (data not shown). Although these results are confusing they do not exclude a role in gene regulation for the regulatory subunit. Furthermore, the catalytic subunit may modulate gene activity by the phosphorylation of relevant proteins.
Both the induction and repression of genes from different stages of development have been reported to be regulated by cAMP (1, (11) (12) (13) (14) (15) (16) (17) . It is difficult to envision how CABP1 alone can mediate all these reactions. Additional macromolecules are likely to be involved. The cAMP-dependent protein kinase may serve as another modulator. In addition, those nuclear proteins that are related to CABP1 (Fig. 1) may also constitute some of the control molecules. Furthermore, exogenous cAMP is known to elicit a number of cellular responses, including an increase in cGMP and calcium levels (44, 45) . It is conceivable that at least some of the developmental genes are modulated by these components.
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